BIOLASE, Inc.
BIOL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1 | $5 | $58 | $26 |
| - Cash | $7 | $4 | $30 | $18 |
| + Debt | $18 | $15 | $15 | $18 |
| Enterprise Value | $13 | $15 | $43 | $26 |
| Revenue | $49 | $48 | $39 | $23 |
| % Growth | 1.4% | 23.7% | 72% | – |
| Gross Profit | $17 | $16 | $17 | $6 |
| % Margin | 34% | 32.8% | 42.2% | 27.1% |
| EBITDA | -$15 | -$25 | -$13 | -$14 |
| % Margin | -31.4% | -52.2% | -34.4% | -60.8% |
| Net Income | -$21 | -$29 | -$16 | -$17 |
| % Margin | -42% | -59.1% | -41.2% | -73.9% |
| EPS Diluted | -16.14 | -413.19 | -273.41 | -688.19 |
| % Growth | 96.1% | -51.1% | 60.3% | – |
| Operating Cash Flow | -$14 | -$27 | -$17 | -$13 |
| Capital Expenditures | -$1 | -$4 | -$1 | -$0 |
| Free Cash Flow | -$15 | -$30 | -$17 | -$13 |